EPS (Diluted) for ResMed (RMD)
According to ResMed's latest reported financial statements, the company's current diluted EPS (TTM) is $10.11. Diluted earnings per share (EPS) is net income divided by the diluted weighted-average shares outstanding over the period. It expresses profit on a per-share basis — the figure investors use to value an individual share — and accounts for potential dilution from options, RSUs, and convertible securities.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
RMD
Currently viewingEPS (Diluted)Switch metric
TTM (last 4 quarters)
$10.11
YoY change
+37.4%
5Y CAGR
+17.4%
Peak year (2025)
$9.51
Latest annual
$9.51
EPS (Diluted) history chart for ResMed (RMD) from 1993 to 2025
EPS (Diluted) history table for ResMed (RMD) from 1993 to 2025
| Fiscal year | Period ended | Reported | EPS (Diluted) | YoY |
|---|---|---|---|---|
| 2025 | $9.51 | +37.4% | ||
| 2024 | $6.92 | +13.6% | ||
| 2023 | $6.09 | +14.9% | ||
| 2022 | $5.30 | +63.6% | ||
| 2021 | $3.24 | -24.1% | ||
| 2020 | $4.27 | +52.5% | ||
| 2019 | $2.80 | +27.9% | ||
| 2018 | $2.19 | -8.8% | ||
| 2017 | $2.40 | -3.6% | ||
| 2016 | $2.49 | +0.8% | ||
| 2015 | $2.47 | +3.3% | ||
| 2014 | $2.39 | +13.8% | ||
| 2013 | $2.10 | +22.8% | ||
| 2012 | $1.71 | +18.8% | ||
| 2011 | $1.44 | +17.1% | ||
| 2010 | $1.23 | +29.5% | ||
| 2009 | $0.95 | +35.7% | ||
| 2008 | $0.70 | +62.8% | ||
| 2007 | $0.43 | -25.9% | ||
| 2006 | $0.58 | +26.1% | ||
| 2005 | $0.46 | +12.2% | ||
| 2004 | $0.41 | +24.2% | ||
| 2003 | $0.33 | +17.9% | ||
| 2002 | $0.28 | +220.0% | ||
| 2001 | $0.09 | -48.5% | ||
| 2000 | $0.17 | +30.8% | ||
| 1999 | $0.13 | +47.6% | ||
| 1998 | $0.09 | +38.1% | ||
| 1997 | $0.06 | +59.5% | ||
| 1996 | $0.04 | 0.0% | ||
| 1995 | $0.04 | +77.8% | ||
| 1994 | $0.02 | +50.0% | ||
| 1993 | $0.01 | — |
EPS (Diluted) values are taken from ResMed's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
2025's annual diluted EPS for ResMed (RMD) came in at $9.51 – surged 37.4% year-over-year.
ResMed diluted EPS compound annual growth for the 2020–2025 (5 years) window is +17.4%, sustaining 4 straight years of year-over-year growth.
2025 marks the peak diluted EPS at $9.51, with the historical low of $0.01 recorded in 1993.
ResMed (RMD) sits 7th of 8 Healthcare peers we track on this metric, against a peer median of $13.16.
ResMed EPS (Diluted) by Year
ResMed EPS (Diluted) 2025: $9.51
ResMed diluted EPS in 2025 was $9.51, surged 37.4% from 2024. This figure represents the highest annual value in the available history.
ResMed EPS (Diluted) 2024: $6.92
ResMed diluted EPS in 2024 was $6.92, grew 13.6% from 2023.
ResMed EPS (Diluted) 2023: $6.09
ResMed diluted EPS in 2023 was $6.09, grew 14.9% from 2022.
ResMed EPS (Diluted) 2022: $5.30
ResMed diluted EPS in 2022 was $5.30, surged 63.6% from 2021.
ResMed EPS (Diluted) 2021: $3.24
ResMed diluted EPS in 2021 was $3.24.
See more financial history for ResMed (RMD).
Sector peers — EPS (Diluted)
Companies in the same sector as ResMed, ranked by their latest diluted EPS.
| Company | EPS (Diluted) | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $23.03 | Healthcare |
| Eli Lilly and Company (LLY) | $22.95 | Healthcare |
| Amgen Inc. (AMGN) | $14.23 | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $13.23 | Healthcare |
| AstraZeneca PLC (AZN) | $13.08 | Healthcare |
| Johnson & Johnson (JNJ) | $11.03 | Healthcare |
| Merck & Co., Inc. (MRK) | $7.28 | Healthcare |
| AbbVie Inc. (ABBV) | $2.37 | Healthcare |
Frequently asked questions
What is ResMed's diluted EPS?
- Latest reported diluted EPS for ResMed (RMD) is $10.11 (period ending December 31, 2025).
How has ResMed diluted EPS changed year-over-year?
- ResMed (RMD) diluted EPS changed +37.4% year-over-year on the latest annual filing.
What is the long-term growth rate of ResMed diluted EPS?
- ResMed (RMD) diluted EPS compound annual growth rate is +17.4% over the most recent 5 years available.
When did ResMed diluted EPS hit its highest annual value?
- ResMed diluted EPS reached its highest annual value of $9.51 in 2025.
What was ResMed diluted EPS in 2024?
- ResMed (RMD) diluted EPS in 2024 was $6.92.
What was ResMed diluted EPS in 2025?
- ResMed (RMD) diluted EPS in 2025 was $9.51.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
RMD Overview
Company profile, financial tools, and key metrics
RMD Revenue Counter
Earns $171.17 every second. See per minute, hour, and day.
RMD Earnings Counter
Earns $47.12 per second net profit. See per minute, hour, and day.
RMD Economic Scale
Exceeds Eswatini's GDP. Compare with world economies.
RMD What If Invested
What if you had invested $1,000? See historical returns from any date.
RMD How It Makes Money
Discover visual breakdown of $5.40B in revenue — where it comes from and where it goes.
RMD Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
RMD Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
RMD Daily Price Character
Balanced · 50.4% historical win rate (green days). Streaks & record days.
RMD Buybacks
1.42% TTM buyback yield. Shareholder yield & SBC comparison.
RMD Stock Split History
4 splits on record. Dates, ratios, and cumulative multiple.
RMD Dividend Profile
Yield: 1.10%. Safety: 6/8. See full history.
RMD Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
RMD Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.